In order to identify which E3s act in a pro-viral or anti-viral capacity against HIV-1 in primary activated CD4+ T cells, we used an arrayed CRISPR-knockout (KO)-compatible spreading HIV-1 infection assay (26, 27). The gene discussed is CD4; the disease is HIV-1 infection.